Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the Sword of Damocles above us...
In this article the authors aim to give an overview of the current literature concerning the application of OCT-A in geographic atrophy (GA). GA is a disease characterised by loss of outer retinal layers including photoreceptors, degeneration of the retinal...
Case report An 89-year-old lady with dementia was referred to me out of hours by her GP with a few days history of an angry looking left eye for suspected elevated intraocular pressure (IOP). I discovered that this lady first...
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...
From now on there will be one major annual exhibition, 100% Optical at London’s ExCeL exhibition centre, which has full industry support from the FMO and other major optical bodies.
Over one million people have completed The Oliver McGowan Mandatory Training on Learning Disability and Autism’s e-learning in the year since it was launched.
Moorfields Eye Charity launches its impact report showing that it has grown to become the leading charity in the UK funding research into eye health and innovation and improvement in patient care.
2024 was an exceptional year for us at Kabgayi Eye Unit (KEU). We hosted Rwanda’s first-ever international ophthalmology conference, established the Kabgayi Learning and Simulation Centre (KLAS) – a dedicated wet lab and skills transfer centre, and launched our training...